business news in context, analysis with attitude

• The Food Marketing Institute (FMI) announced the four recipients of the 19th annual Store Manager Awards:

Category A: (1-49 stores): Al Gartner, Lunds & Byerlys, Woodbury, Minnesota
 
Category B (50-199 stores): Kathy Sweigert, Giant Martin’s, State College, Pennsylvania
 
Category C (200+ stores): Pam Hudson, Dillons Food Stores, a division of The Kroger Co., Hutchinson, Kansas
 
Category D (International): Joanne Walker, SPAR Northern Ireland/Henderson Group, Co. Down, N. Ireland
 
2018 Store Manager People’s Pick (chosen via facebook vote): Mitch Cochran, Food City, Cleveland, Tennessee


• Temkin Group is out with its annual Temkin Trust Ratings (TTR)., which benchmarks the level of trust that consumers have with 318 companies across 20 industries.

Wegmans is the top ranked supermarket at 79 percent, followed by HEB at 77 percent.

The highest ranked business in the country was USAA bank.

According to Temkin, “The supermarket industry earned the highest average TTR (66%), followed by investment firms (62%), insurance companies (61%), and auto dealers (61%). TV/Internet service providers earned the lowest average TTR (32%), well below the next lowest industry, health plans (49%).”


• The Puget Sound Business Journal reports that Starbucks, in calling China a main growth engine for the foreseeable future, now is projecting that “it will have 6,000 stores in 230 Chinese cities by 2022, which also means tripling its revenue and doubling its operating income in the country. This is up from the company's previous target of 5,000 stores by 2021.”


Reuters reports that “Allergan Inc. was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to stop rivals from selling generic versions of Restasis, its medication to treat dry-eye disease.”

The story says that the four retailers “accused Allergan of illegally preserving its monopoly by obtaining illegal patents, suing rivals that challenged those patents and transferring the patents to a sovereign Native American tribe, New York’s Saint Regis Mohawk Tribe, to escape scrutiny by U.S. courts.

“The retailers said generic Restasis would have been on the U.S. market by May 2014 but for Allergan’s activities, and that the Dublin, Ireland-based company should pay triple and other damages for its anticompetitive conduct.”
KC's View: